ArticleThe Journal of urology2013
Re: effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.
Anthony AtalaPubMed ↗Publisher ↗
No numbers read from the abstract.